Substitution reactions of cis-platinum(II) complexes containing bidentate N,N-donor pyridinecarboxamide ligands with different substituents

被引:4
作者
Papo, Tshephiso R. [1 ]
Jaganyi, Deogratius [2 ,3 ]
Mambanda, Allen [1 ]
机构
[1] Univ KwaZulu Natal, Sch Chem & Phys, Pietermaritzburg, South Africa
[2] Mt Kenya Univ, Sch Pure & Appl Sci, Thika, Kenya
[3] Durban Univ Technol, Fac Appl Sci, Dept Chem, Durban, South Africa
基金
新加坡国家研究基金会;
关键词
N-(4-substituted-phenyl)-(2-pyridine-carboxamide); pyridine carboxamide; Pt(II) complexes; ligand substitution; consecutive reactions; PT(II) COMPLEXES; CISPLATIN ANALOGS; AQUA-LIGANDS; DNA-BINDING; CHEMISTRY; LABILITY;
D O I
10.1080/00958972.2022.2149327
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Substitution reactions of [2-(pyridinecarboxamide)dichloride Pt(II)] [PtCl2], [N-phenyl-(2-pyridinecarboxamide)dichloride Pt(II)] [PhPtCl2], [N-(4-methylphenyl)-2-pyridinecarboxamide)dichloride Pt(II)] [CH3PhPtCl2], [N-(4-methoxyphenyl)-(2-pyridine-carboxamide)dichloride Pt(II)] [CH3OPhPtCl2] and [N-(4-fluorophenyl)-(2-pyridinecarboxamide)dichloride Pt(II)] [FPhPtCl2], with nucleophiles; thiourea (TU), N,N '-dimethylthiourea (DMTU) and N,N,N ',N '-tetramethylthiourea (TMTU) were studied under pseudo first-order conditions. The rates of substitution were investigated as a function of nucleophile concentration and temperature using stopped-flow and UV-visible absorption spectrophotometers. Substitutions of the two coordinated chloride ligands of the Pt(II) complexes occur consecutively, with the first substitution occurring opposite the coordinated pyridyl. The observed pseudo first-order rate constants regressed linearly with concentration of the incoming nucleophiles according to the equation k(obs) = k(2)[Nu]. The highest substitution rates were measured for PtCl2, which is attributed to the unsubstituted non-leaving carboxamide ligand. The Pt(II) center of this complex is the most electrophilic as a result of the strong withdrawal of electron density through pi-resonance by the carboxamide group. The introduction of a 4 '-substituted phenyl group on the amido N of the carboxamide reduces the reactivity of the complexes due to proportional electronic effects from the ancillary substituents on the phenyl ring as well as its conformational disposition with respect to the plane of the complex. The order of reactivity of studied nucleophiles is TU > DMTU > TMTU. The substitution is associatively activated as supported by the negative entropy of activation values for the reactions.
引用
收藏
页码:2557 / 2573
页数:17
相关论文
共 41 条
  • [1] Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin
    Abu-Surrah, AS
    Kettunen, M
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (11) : 1337 - 1357
  • [2] Atwood J.D., 1997, INORGANIC ORGANIC RE, P32
  • [3] Banjo Semire, 2013, Pakistan Journal of Scientific and Industrial Research Series A-Physical Sciences, V56, P14
  • [4] Triarylboryl-functionalized dibenzoylmethane and its phosphorescent platinum(II) complexes
    Blight, Barry A.
    Ko, Soo-Byung
    Lu, Jia-Sheng
    Smith, Larissa F.
    Wang, Suning
    [J]. DALTON TRANSACTIONS, 2013, 42 (28) : 10089 - 10092
  • [5] Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs
    Brabec, V
    Kasparkova, J
    [J]. DRUG RESISTANCE UPDATES, 2005, 8 (03) : 131 - 146
  • [6] Understanding the local reactivity in polar organic reactions through electrophilic and nucleophilic Parr functions
    Domingo, Luis R.
    Perez, Patricia
    Saez, Jose A.
    [J]. RSC ADVANCES, 2013, 3 (05) : 1486 - 1494
  • [7] Fernandez-Pol JA, 2001, ANTICANCER RES, V21, P931
  • [8] Frisch M.J., 2009, Gaussian09, Revision D. 01, DOI [DOI 10.1159/000348293, 10.1159/000348293]
  • [9] Electronic tuning of the lability of Pt(II) complexes through π-acceptor effects.: Correlations between thermodynamic, kinetic, and theoretical parameters
    Hofmann, A
    Jaganyi, D
    Munro, OQ
    Liehr, G
    van Eldik, R
    [J]. INORGANIC CHEMISTRY, 2003, 42 (05) : 1688 - 1700
  • [10] Holford J, 1998, ANTI-CANCER DRUG DES, V13, P1